Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 1/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30454901 | 1.00 | PYCR1 (0.51) | PYCR1CSNK2A1KDM4ETDP1GAA | |
| SCHEMBL4171690 | 0.86 | KDM4E (0.50) | CSNK2A1KDM4ETDP1GAAMAPT | |
| SCHEMBL14097993 | 0.84 | SLC6A4 (0.43) | PYCR1CSNK2A1KDM4ETDP1 | |
| SCHEMBL27869012 | 0.83 | PYCR1 (0.49) | PYCR1KDM4ETDP1CASP1HSD17B10 | |
| SCHEMBL15820790 | 0.83 | CSNK2A1 (0.43) | PYCR1CSNK2A1TDP1GAAMAPT | |
| SCHEMBL15820910 | 0.80 | HPGD (0.46) | PYCR1CSNK2A1KDM4EGAAMAPT | |
| SCHEMBL12257908 | 0.80 | ACHE (0.50) | KDM4ETDP1GAAMAPTHTT | |
| SCHEMBL1237860 | 0.80 | APLNR (0.58) | MAPTTSHRALDH1A1 | |
| SCHEMBL6674914 | 0.79 | MAPT (0.65) | KDM4EGAAMAPTHTTTSHR | |
| SCHEMBL8032757 | 0.79 | MAOB (0.50) | GAAMAPTHTTTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4614641-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-10 | — | — | EP | claimed |
| EP-4611154-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| EP-4611095-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| EP-4611093-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| US-20250273816-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK INNOVATION CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273821-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK IE TECHNOLOGY CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273741-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK IE TECHNOLOGY CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273815-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK INNOVATION CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250023193-A1 | HYBRID SEPARATOR AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | SK INNOVATION CO., LTD. (KR) | 2025-01-16 | — | — | US | claimed |
| EP-4492531-A2 | HYBRID SEPARATOR AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | SK Innovation Co., Ltd. (KR) | 2025-01-15 | — | — | EP | claimed |
| EP-4614641-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-10 | — | — | EP | disclosed |
| EP-4611095-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | disclosed |
| EP-4611154-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | disclosed |
| EP-4611093-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-20250273815-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK INNOVATION CO., LTD. (KR) | 2025-08-28 | — | — | US | disclosed |
| US-20070293511-A1 | Crf Receptor Antagonists and Methods | SB PHARMCO PUERTO RICO INC. AND NEUROCRINE BIOSCIENCES, INC., A CORPORATION | 2007-12-20 | — | — | US | disclosed |
| WO-2007103432-A2 | USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS | NOVARTIS AG (CH) | 2007-09-13 | — | — | WO | disclosed |
| EP-1708710-A1 | PYRAZOLO[1,5-A]PYRIMIDIN-7-YL-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | Novartis AG (CH) | 2006-10-11 | — | — | EP | disclosed |
| US-20050222171-A1 | Organic compounds | NOVARTIS AG (CH) | 2005-10-06 | — | — | US | disclosed |
| WO-2005070431-A1 | PYRAZOLO[1,5-A]PYRIMIDIN-7-YL-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | NOVARTIS AG (CH) | 2005-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293511-A1 | Crf Receptor Antagonists and Methods | CRHR1, CRHR2, CRH | PYCR1 1525/4885CSNK2A1 1607/4885KDM4E 4388/4885 |
| US-20050222171-A1 | Organic compounds | JAK1, MAP3K5, MAP3K7 | PYCR1 672/4885CSNK2A1 288/4885KDM4E 1049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.